| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |